BioLineRx Achieves Enrollment Target in Phase 3 GENESIS Trial for Planned Interim Analysis August 19, 2020 PR - BLRX Achieves Target Enrollment in GENESIS interim (Hebrew) (final for distribution).pdf 79.2 KB